Key result
Low-dose aspirin reduced urinary thromboxane B2 excretion by 65% but only weakly inhibited collagen-induced ATP and 5-HT secretion in healthy male volunteers.
Why the study?
Does low-dose aspirin completely inhibit platelet secretion in healthy volunteers?
Does low-dose aspirin completely inhibit platelet secretion in healthy volunteers?
Low-dose aspirin incompletely inhibits platelet secretion induced by strong stimuli like collagen or thrombin, despite near-complete inhibition of thromboxane formation.
Answers are grounded in this paper and cite their sources.
Low-dose aspirin may incompletely inhibit platelet secretion; leaves open whether adjunctive strategies are needed in patients.
This study determines the effects of low-dose oral acetylsalicylic acid (Aspirin) on platelet aggregation and dense granule secretion in relation to inhibition of thromboxane formation. In addition, possible modifications of inhibition of platelet function by iloprost and linsidomine (SIN-1) were also studied. Aspirin (40 mg/day) was administered to 15 healthy male non-smoking volunteers for 8 consecutive days. Platelet function was measured ex vivo before and 12 h after the last drug intake. At the same times urinary excretion of thromboxane B(2) (TXB(2)) and 6-oxo-PGF(1α) were determined. Asirin treatment resulted in a significant (P < 0.01), by 65%, reduction of urinary TX B(2) excretion, whereas urinary excretion of 6-oxo-PGF(1α) remained unchanged, demonstrating the expected selectivity of low-dose aspirin for the platelet cyclooxygenase. There was also a nearly complete (93-95%) inhibition of collagen (0.3-5 μg/ml)-induced thromboxane formation in platelets. However, collagen-induced ATP-and 5-HT secretion was much less inhibited by aspirin and was reduced by only 20% at 5 μg/ml collagen. Similar results were obtained with ADP while thrombin (> 1.2 IU/ml)-induced 5-HT secretion was not antagonized at all. Also aspirin did not affect the inhibition of platelet function by iloprost and linsidomine (SIN-1). It is concluded that stimulation of platelet secretion by stronger stimuli, such as collagen or thrombin, is largely cyclooxygenase-independent and may not be detected by measuring serum thromboxane levels. This may be relevant for clinical situations with shear-stress-induced platelet activation, for example at carotis stenoses or other types of atherosclerotic plaques.
No takes yet. Share an insight, caveat, or question.
Braun et al. (1994) studied Healthy volunteers (n=15). Aspirin vs. Baseline (before drug intake) was evaluated on Urinary excretion of thromboxane B(2) (TXB(2)) (65% reduction, p=< 0.01). Low-dose aspirin reduced urinary thromboxane B2 excretion by 65% but only weakly inhibited collagen-induced ATP and 5-HT secretion in healthy male volunteers.
Synapse has enriched 10 related papers. Consider them for comparative context: